#multiple-myeloma

[ follow ]
#immunotherapy #greg-iles #mississippi #natchez-burning #memoir #cancer-treatment #car-t #bispecific-antibodies
Cancer
fromFast Company
1 week ago

Why a rare blood cancer has become a testing ground for cancer drug innovation

Multiple myeloma drives advanced gene and antibody therapies, transforming cancer into a chronic, high-cost condition while extending patient survival.
#greg-iles
fromFortune
2 weeks ago
Books

Greg Iles, author of 'Natchez Burning' trilogy, dies at 65 after decades-long battle with cancer

fromFortune
2 weeks ago
Books

Greg Iles, author of 'Natchez Burning' trilogy, dies at 65 after decades-long battle with cancer

more#greg-iles
fromFast Company
1 month ago

20 years ago, this Fast Company editor was given 18 months to live. Here's what his cancer journey has taught him about work and life

Receiving a diagnosis of multiple myeloma, a rare and incurable blood cancer, created a life-altering reality for Jon Gluck, pushing him toward coping through work.
Health
Health
fromwww.esquire.com
1 month ago

I Was Diagnosed with Incurable Cancer. This Futuristic Treatment Could Save Me.

Patient diagnosed with multiple myeloma in 2003, initially given eighteen months to live; twenty-one years later, survival story continues.
Cancer
fromwww.theguardian.com
2 months ago

Blood cancer patients in England first in world to be offered Trojan horse' drug

England is the first to offer a pioneering Trojan horse drug for blood cancer, targeting and destroying cancer cells effectively.
Cancer
fromIntelligencer
3 months ago

What's It Like to Have Cancer for 20 Years?

Jonathan Gluck's story reveals a rare narrative of living long-term with an incurable cancer, highlighting survival rates and personal coping mechanisms.
Cancer
fromwww.eastbaytimes.com
4 months ago

Cancer Support Community's Lafayette expansion reflects a different approach to recovery care

Dexter Louie transitioned from a cancer surgeon to a patient, highlighting the importance of community support during his battle with multiple myeloma.
[ Load more ]